Overview
Status
Active
Registry date
2019-11-19
Share capital
5,000.00 PLN
Registered address
ul. Jurija Gagarina 7/47, 87-100 Toruń, Poland
Electronic delivery address
AE:PL-90108-66898-EJSIJ-24
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 53 days late).
- 2025filed
- 202427/05/2025
- 202318/06/2024
- 202228/06/2023
- 202106/09/2022
- 202002/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.58kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 538.72MedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 3.04kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 2.17kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Maciej Wojciech Gagat – President of the Management Board
Jan Tomasz Zabrzyński – Vice President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 24 | $324.15 | 24% | |
Maciej Wojciech Gagatage 41 | 38 | $513.24 | 38% |
Jan Tomasz Zabrzyńskiage 39 | 38 | $513.24 | 38% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-12-01.
03 1090 1506 0000 0001 4389 7393
73 1090 1506 0000 0001 4389 7394
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Torunia |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| InventionbioS.A. | $17,762,977.76 | inventionbio.pl | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Plan Biosp. z o.o. | $3,404.49 | biotrem.pl | ||
| Greenetoxsp. z o.o. | $3,013.95 | greenetox.com | ||
| Passio Human Microbiomesp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Passio Biomaterialssp. z o.o. | $0.00 | passio.pl | ||
| SONO Livesp. z o.o. | – | sonolive.eu |
FAQ
The main business activity of CTR Lab focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on November 19, 2019.
The headquarters is located at: ul. Jurija Gagarina 7, 87-100 Toruń.
The management board includes Jan Tomasz Zabrzyński (Vice President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $2,253, representing an increase of 61.7% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $309. For comparison, in 2023 the loss was $1,372, meaning the company reduced its loss by 78.6%.
The largest operating cost category falls under external services. This category amounted to $1,620 in 2024, representing 63% of all operating expenses.
Last updated: 2026-04-16